Search Results - "Girodet, P O"

Epidemiology of COPD by Raherison, C, Girodet, P-O

“…* Dept of Respiratory Diseases, CHU Bordeaux, Institute of Public Health, Epidemiology and Development, University of Bordeaux 2, and # Dept of Pharmacology,…”
Get full text

Mast cell adhesion to bronchial smooth muscle in asthma specifically depends on CD51 and CD44 variant 6 by Girodet, P.-O, Ozier, A, Trian, T, Begueret, H, Ousova, O, Vernejoux, J.-M, Chanez, P, Marthan, R, Berger, P, Tunon de Lara, J.M

“…To cite this article: Girodet P-O, Ozier A, Trian T, Begueret H, Ousova O, Vernejoux J-M, Chanez P, Marthan R, Berger P, Tunon de Lara JM. Mast cell adhesion…”
Get full text

Asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) longitudinal profiling study by Silkoff, P E, Strambu, I, Laviolette, M, Singh, D, FitzGerald, J M, Lam, S, Kelsen, S, Eich, A, Ludwig-Sengpiel, A, Hupp, G C, Backer, V, Porsbjerg, C, Girodet, P O, Berger, P, Leigh, R, Kline, J N, Dransfield, M, Calhoun, W, Hussaini, A, Khatri, S, Chanez, P, Susulic, V S, Barnathan, E S, Curran, M, Das, A M, Brodmerkel, C, Baribaud, F, Loza, M J

“…Asthma is a heterogeneous disease and development of novel therapeutics requires an understanding of pathophysiologic phenotypes. The purpose of the ADEPT…”
Get full text

Longitudinal stability of asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) study by Silkoff, P E, Laviolette, M, Singh, D, FitzGerald, J M, Kelsen, S, Backer, V, Porsbjerg, C, Girodet, P O, Berger, P, Kline, J N, Khatri, S, Chanez, P, Susulic, V S, Barnathan, E S, Baribaud, F, Loza, M J

“…Asthma is a biologically heterogeneous disease and development of novel therapeutics requires understanding of pathophysiologic phenotypes. There is…”
Get full text

Mast cell myositis: a new feature of allergic asthma? by Berger, P., Girodet, P.‐O., Manuel Tunon‐de‐Lara, J.

“…There is some evidence that, in asthma, mast cells infiltrate the airway smooth muscle layer and, as a consequence, alter the functional and structural…”
Get full text

Atypical antipsychotics: From potassium channels to torsade de pointes and sudden death by TITIER, Karine, GIRODET, Pierre-Olivier, VERDOUX, Hélène, MOLIMARD, Mathieu, BEGAUD, Bernard, HAVERKAMP, Wilhelm, LADER, Malcolm, MOORE, Nicholas

“…Syncope and sudden death are features of schizophrenia that can be attributed to ischaemic heart disease, the use of antipsychotics (because of proarrhythmia…”
Get full text

Paradoxal effect of salbutamol in an in vitro model of bronchoprotection by Girodet, P.O., Berger, P., Martinez, B., Marthan, R., Advenier, C., Molimard, M.

“…Salbutamol‐induced hyperresponsiveness to acetylcholine was investigated in human and guinea‐pig isolated airways and cultured human airway smooth muscle…”
Get full text

Therapeutic management and adjustment of long-term treatment by Drummond, D, Mazenq, J, Lezmi, G, Cros, P, Coutier, L, Desse, B, Divaret-Chauveau, A, Dubus, J-C, Girodet, P-O, Kiefer, S, Llerena, C, Pouessel, G, Troussier, F, Werner, A, Schweitzer, C, Lejeune, S, Giovannini-Chami, L

Get more information

Les bronchodilatateurs exposent-ils à des risques cardiaques ? by Girodet, P.-O.

Get full text

What is the therapeutic response to corticosteroid in smokers with asthma? by Girodet, P-O

“…Inhaled corticosteroid is the first choice antiinflammatory therapy for chronic asthma. International guidelines are based upon data obtained in the…”
Get more information

Synthesis and anti-histaminic evaluation of N-phenyl-(alkyl)-5-(dialkylamino)methyl-2-amino-2-oxazolines by Bosc, J J, Pourageaud, F, Girodet, P O, Molimard, M, Jarry, C

“…New N-phenyl(alkyl)-5-(dialkylamino)methyl-2-amino-2-oxazolines, 5a-e, have been synthesized from the corresponding…”
Get more information

Multi-professional lung cancer disclosure to change anxiety and depression: an exploratory study by Cousson-Gélie, F, Vernejoux, J-M, Bazex-Chanteloube, H, Raherison, C, Ozier, A, Girodet, P-O, Taytard, A

Get more information

Inhaled triple therapy in chronic obstructive pulmonary disease: Lancet by Molimard, Mathieu, Girodet, P. O., Moore, Nicholas

Get full text

Validated and longitudinally stable asthma phenotypes based on cluster analysis of the ADEPT study by Loza, Matthew J, Djukanovic, Ratko, Chung, Kian Fan, Horowitz, Daniel, Ma, Keying, Branigan, Patrick, Barnathan, Elliot S, Susulic, Vedrana S, Silkoff, Philip E, Sterk, Peter J, Baribaud, Frédéric

“…Asthma is a disease of varying severity and differing disease mechanisms. To date, studies aimed at stratifying asthma into clinically useful phenotypes have…”
Get full text

IgE and respiratory disease by Girodet, P O, Casset, A, Magnan, A, de Blay, F, Chanez, P, Tunon De Lara, J M

“…IgE is known to provide the biological basis for allergy and immediate hypersensitivity. However, recent data provide some evidence that IgE responses are…”
Get more information

B34 LUNG MACROPHAGE ACTIVATION IN HEALTH AND DISEASE: Immunophenotypic Characterization Of Human Lung Macrophages In Asthma by Girodet, P-O, Nguyen, D, Mancini, J D, Zhou, X, Israel, E, Cernadas, M

Get full text

C97 AIRWAY SMOOTH MUSCLE: TRANSLATING REACTOME TO THERAPEUTIC DISCOVERY: A Double-Blind, Placebo-Controlled Trial Of Gallopamil For Severe Asthma by Girodet, P-O, Dournes, G, Thumerel, M, Begueret, H, Dos Santos, P, Ozier, A, Dupin, I, Montaudon, M, Trian, T, Laurent, F, Marthan, R, Berger, P

Get full text

D29 FRESH PERSPECTIVES ON AIRWAY REMODELING: FROM THE ROCKY MOUNTAIN HIGH TO COUNTRY ROADS: Increased Bronchial Smooth Muscle Mass And Mitochondrial Biogenesis In Non-Severe Asthma by Girodet, P-O, Allard, B, Thumerel, M, Begueret, H, Dupin, I, Ousova, O, Maurat, E, Ozier, A, Trian, T, Marthan, R, Berger, P

Get full text

Asthma exacerbations: pharmacological prevention by Grassin-Delyle, S, Girodet, P-O

“…Asthma exacerbations are responsible for many emergency medical interventions and account for a significant proportion of the health costs of the disease…”
Get more information

Phytalgic registered , a food supplement, vs placebo in patients with osteoarthritis of the knee or hip: a randomised double-blind placebo-controlled clinical trial by Jacquet, A, Girodet, P-O, Pariente, A, est, K, Mallet, L, Moore, N

“…Introduction The medicinal treatment of osteoarthritis (OA) is mostly symptomatic to relieve pain and incapacity with analgesics and non-steroidal…”
Get full text